|
CDKN2AIPNL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78819999999891E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88719999999876E-05 |
| Normal-vs-Stage2 |
1.723550E-03 |
| Normal-vs-Stage3 |
4.344000E-02 |
| Normal-vs-Stage4 |
9.291200E-01 |
| Stage1-vs-Stage2 |
6.489600E-01 |
| Stage1-vs-Stage3 |
4.648200E-01 |
| Stage1-vs-Stage4 |
9.706400E-02 |
| Stage2-vs-Stage3 |
4.079600E-01 |
| Stage2-vs-Stage4 |
5.619900E-02 |
| Stage3-vs-Stage4 |
1.973640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.86830000000038E-05 |
| Normal-vs-AfricanAmerican |
4.19880000002149E-06 |
| Normal-vs-Asian |
5.991000E-01 |
| Caucasian-vs-AfricanAmerican |
5.848600E-01 |
| Caucasian-vs-Asian |
4.714200E-01 |
| AfricanAmerican-vs-Asian |
5.402000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36639999999788E-05 |
| Normal-vs-Female |
1.255900E-03 |
| Male-vs-Female |
5.202400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.261910E-03 |
| Normal-vs-Extreme_Weight |
1.632060E-04 |
| Normal-vs-Obese |
8.403900E-03 |
| Normal-vs-Extreme_Obese |
1.417460E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.751200E-01 |
| Normal_Weight-vs-Obese |
3.439400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.024800E-01 |
| Extreme_Weight-vs-Obese |
2.254400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.712600E-01 |
| Obese-vs-Extreme_Obese |
2.945400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.279380E-01 |
| Normal-vs-Age(41-60Yrs) |
2.480800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.09349999999997E-05 |
| Normal-vs-Age(81-100Yrs) |
4.922100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.151600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.292630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.038600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.037600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.145400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.556850E-04 |
| Normal-VS-Type2 PRCC |
1.969830E-02 |
| Normal-VS-KIRP CIMP |
2.356800E-04 |
| Normal-VS-Unclassified PRCC |
1.421350E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.973200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.539020E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.486200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.482500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.381400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.581200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.079200E-03 |
| Normal-vs-N1 |
2.419400E-01 |
| Normal-vs-N2 |
2.947200E-01 |
| N0-vs-N1 |
5.499400E-01 |
| N0-vs-N2 |
1.701830E-02 |
| N1-vs-N2 |
1.202970E-01 |
|
|
